Mechanism of inhibitory effect of 3-hydroxykynurenine on erythropoiesis in patients with renal insufficiency

Advances in Experimental Medicine and Biology

Volumn 527, Issue , 2003, Pages 375-380

  Pawlak, Dariusz ^a   Koda, Mariusz ^a   Wołczyński, Sawomir ^a   Myśliwiec, Michal ^a   Buczko, Wlodzimierz ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYKYNURENINE; CREATININE; ERYTHROPOIETIN; HEMOGLOBIN;

ADULT; AGED; BLOOD LEVEL; CELL CULTURE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; ERYTHROCYTE COUNT; ERYTHROPOIESIS; FEMALE; HEMATOCRIT; HEPATOMA CELL; HUMAN; HUMAN CELL; KIDNEY FAILURE; MALE; PRIORITY JOURNAL;

EID: 1042279501     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0135-0_43     Document Type: Conference Paper

References (18)

1. K.U. Eckardt, Pathophysiology of renal anemia, Clin. Nephrol. 53, S2-S8 (2000).
2. I. Macdougall, Role of uremic toxins in exacerbating anemia in renal failure, Kidney Int. 59, S67-S72 (2001).
3. W. Jelkman, T. Hellwing-Burgel, Biology of erythropoietin, Adv. Exp. Med. Biol. 502, 169-87 (2001).
4. A.J. Erslev, A. Besarab, Erythropoietin in the pathogenesis and treatment of the anemia of chronic renal failure, Kidney Int. 51, 622-630 (1997).
5. K. Saito, S. Fujigaki, M.P. Heyes, K. Shibata, M. Takemura, H. Fujii, H. Wada, A. Noma, M. Seishima, Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency, Am. J. Physiol. 279, F565-F572 (2000).
6. E.W. Holmes, S.E. Kahan, Tryptophan distribution and metabolism in experimental chronic renal insufficiency, Exp. Mol. Pathol. 46, 89-101 (1987).
7. E.W. Holmes, P.M. Russell, G.J. Kinzler, C.R. Reckard, R.C. Flanigan, K.D. Thompson, E.W. Berme, Oxidative tryptophan metabolism in renal allograft recipients: increased kynurenine synthesis is associated with inflammation and OKT3 therapy, Cytokine 4, 205-213 (1992).
8. D. Pawlak, A. Tankiewicz, P. Mysliwiec, W. Buczko, Tryptophan metabolism via kynurenine pathway in experimental chronic renal failure, Nephron 90, 328-335 (2002).
9. D. Pawlak, A. Tankiewicz, W. Buczko, Kynurenine and its metabolites in the rat with experimental renal insufficiency, J. Physiol. Pharmacol. 52, 755-766 (2001).
10. D. Pawlak, K. Pawlak, J. Malyszko, M. Mysliwiec, W. Buczko, Accumulation of toxic products degradation of kynurenine in hemodialyzed patients, Int. Urol. Nephrol. 33, 399-404 (2001).
11. R. Buchi, D. Alberati-Gani, P. Malherbe, C. Kohler, C. Broger, A.M. Cesura, Cloning and functional expression of a soluble form of kynurenine/α-aminoadipate aminotransferase from rat kidney, J. Biol. Chem. 270, 29330-29335 (1995).
12. M.P. Heyes, Quantification of 3-hydroxykynurenine in brain by high-performance liquid chromatography and electrochemical detection, J. Chromatogr. 428, 340-344 (1988).
13. A.G. Brox, F. Zhang, H. Guyda, R.F. Gagnon, Subtherapeutic erythropoietin and insulin-like growth factor-1 correct the anemia of chronic renal failure in the mouse, Kidney Int. 50, 937-943 (1996).
14. W.C. Faquin, T.J. Schneider, M.A. Goldberg, Effect of inflammatory cytokines on hypoxia-induced erythropoietin production, Blood 79, 1987-1994 (1992).
15. A.M. Goldberg, A.G. Glass, M.J. Cunningham, F.H. Bunn, The regulated expression of erythropoietin by two human hepatoma cell lines, Proc. Natl. Acad. Sci. USA 84, 7972-7976 (1987).
16. J. Fandrey, S. Frede, W. Ehleben, T. Porwol, H. Acker, W. Jelkamann, Cobalt chloride and desferrioxamine antagonize the inhibition of erythropoietin production by reactive oxygen species, Kidney Int. 51, 492-496 (1997).
17. J. Fandrey, S. Frede, W. Jelkmann, Role of hydrogen peroxide in hypoxia-induced erythropoietin production, Biochem. J. 303, 507-510 (1994).
18. G.L. Wang, G.L. Semenza, Purification and characterization of hypoxia-inducible factor 1, J. Biol. Chem. 270, 1230-1237 (1995).